Ispravljanje hiperopije, hiperopičnog i miješanog astigmatizma excimer laserom: jučer, danas i sutra by Adrian Lukenda et al.
Acta Clin Croat,  Vol. 51,  No. 2,  2012 299
Acta Clin Croat 2012; 51:299-304 Conference Papers – Review
ExCimER LAsER CoRRECtion of HyPERoPiA, 
HyPERoPiC And mixEd AstigmAtism: PAst, PREsEnt, 
And futuRE
Adrian Lukenda1, Željka Karaman martinović1 and miro Kalauz2 
1opto Centar Eye Clinic; 2university department of ophthalmology, Zagreb university Hospital Center, Zagreb, 
Croatia
summARy – The broad acceptance of “spot scanning” or „flying spot“ excimer lasers in the 
last decade has enabled the domination of corneal ablative laser surgery over other refractive surgical 
procedures for the correction of hyperopia, hyperopic and mixed astigmatism. This review outlines 
the most important reasons why the ablative laser correction of hyperopia, hyperopic and mixed 
astigmatism for many years lagged behind that of myopia. most of today‘s scanning laser systems, 
used in the LAsiK and PRK procedures, can safely and effectively perform low, moderate and high 
hyperopic and hyperopic astigmatic corrections. The introduction of these laser platforms has also 
significantly improved the long term refractive stability of hyperopic treatments. in the future, fur-
ther improvements in femtosecond and nanosecond technology, eye-tracker systems, and the deve-
lopment of new customized algorithms, such as the ray-tracing method, could additionally increase 
the upper limit for the safe and predictable corneal ablative laser correction of hyperopia, hyperopic 
and mixed astigmatism.
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Introduction – The Past
Three decades after the first experimental treat-
ment with argon fluoride excimer laser in 1983, cor-
neal ablative laser surgery has become one of the most 
popular surgical treatment modalities for the correc-
tion of refractive errors, such as myopia, hyperopia 
and astigmatism1. The 193-nm ultraviolet excimer la-
ser beams have an exceptional property – they are able 
to ablate very small amounts of tissue with an almost 
negligible thermal effect and minimal damage to the 
surrounding tissue. 
until the advent of the modern “slit scanning” and 
“spot scanning” excimer lasers, the results of the earlier 
corneal surgical procedures for correcting hyperopia, 
hyperopic and mixed astigmatism were unsatisfac-
tory2. one of the earliest methods was keratomileusis, 
as proposed by Barraquer, which involved performing 
central lamellar keratectomy. The resected disk was 
shaped using the cryolathe and sutured back in place. 
A less demanding procedure was keratophakia, where 
the reshaped donor corneal lenticule was inserted in-
trastromally3,4. The procedure was later abandoned 
because of the unsatisfactory results. further develop-
ments led to the emergence of epikeratoplasty, in which 
the donor lenticule was sutured on the mostly intact 
Bowman layer and corneal stroma5. due to the poor 
predictability, this technique was also abandoned. de-
spite initial promising results, hexagonal keratotomy, 
named after the six paracentral corneal incisions used 
to make central cornea steeper, was later abandoned 
due to the glare, photophobia, fluctuating vision and 
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polyopia that often caused irregular astigmatism6,7. in 
the automated lamellar keratoplasty, steepening of the 
cornea was achieved with a deep microkeratome cut, 
leaving behind a thin corneal bed and consequently 
a small amount of ectasia and steepening. This tech-
nique is not used any more because of the poor pre-
dictability and the development of progressive ectasia 
in some patients8.
other corneal surgical procedures for the cor-
rection of hyperopia and hyperopic astigmatism are 
still being used and additionally developed. Corneal 
relaxing incisions, such as astigmatic keratotomy and 
limbal relaxing incisions, are generally used to treat 
hyperopic astigmatism in combination with lenticular 
procedures9,10. The intracorneal artificial lenses that 
are implanted intrastromally have the advantage of 
being reversible. However, in the initial trials some 
intracorneal lenses had to be removed because of 
significant regression and/or formation of epithelial 
cysts11,12. over the past decades, there were many at-
tempts to treat hyperopia and hyperopic astigmatism 
by heating the peripheral cornea. in laser thermal ker-
atoplasty, heating is achieved through the use of light 
from the holmium:yAg or continuous-wave diode 
laser to induce collagen shrinkage in the stroma13,14. 
shrinkage can also be achieved through transfer of the 
radiofrequency energy into the stroma, as in conduc-
tive keratoplasty15. despite the excellent safety profile, 
the stability of these methods has yet to be assessed in 
long term studies. other viable options for surgical 
correction of hyperopia that are beyond the scope of 
this review include implantation of phakic intraocular 
lenses and lens exchange modalities16,17. 
since the first photorefractive keratectomies 
(PRK) were performed on human eyes by mcdonald 
et al. and seiler et al. in 1987 and 1988, the excimer la-
ser treatments of myopia have become the mainstream 
of refractive surgery18,19. The PRK treatment has be-
come a representative of all the corneal surface abla-
tion procedures. depending on how the epithelium is 
removed, these procedures include laser-assisted sub-
epithelial keratectomy (LAsEK), transepithelial PRK 
and Epi-LAsiK. The positive trend in laser ablative 
procedures was further facilitated by the introduc-
tion of laser-assisted in situ keratomileusis (LAsiK) 
by ioannis Pallikaris and colleagues in 1990. today, 
LAsiK is the most common corneal refractive sur-
gery for the correction of myopia20.
Obstacles to successful ablative laser correction of 
hyperopia, mixed and hyperopic astigmatism
until recently, the corneal ablative laser correc-
tion of hyperopia, mixed astigmatism and hyperopic 
astigmatism has lagged behind that of myopia2. The 
reasons for that are numerous.
unlike myopia, the effect of hyperopia on visual 
acuity depends on the available accommodative am-
plitude, which varies between different age groups21. 
in younger patients, between the ages of 22 and 39, 
the mean difference in refraction, measured before 
and after the pharmacologically induced cycloplegia, 
is greater than the difference in older patients22. Thus, 
the exact dioptric power that should be treated is much 
more difficult to determine in a hyperope than it is in 
a myope. in addition, translating the correction from 
the spectacle plane onto the cornea makes the retinal 
image smaller, which can cause a loss of 2 to 4 letters 
on the snellen chart in a +5 hyperope23.
Visual acuity can be influenced by the multifocal-
ity of the eye optics. Along with the spherical aberra-
tion and pupil size, astigmatism can also contribute to 
the multifocality. With the ability of today‘s excimer 
lasers to correct not only astigmatism but also higher 
order aberrations, laser treatments should be carefully 
chosen to suit each eye.
There is still no consensus among refractive sur-
geons about the amount and axis of astigmatism that 
should be treated if there is a significant discrepancy 
between the corneal and total astigmatism. methods 
that include vector analysis of astigmatism of the cor-
nea and total refractive correction can help in outcome 
analysis and improve the results of refractive surger-
ies24. in addition, the current, simplified formulas 
from paraxial optics also fail to take into consideration 
the multiple lens structure of the eye, which could be 
addressed by the laser ablation profiles based on opti-
cal ray-tracing algorithms25.
Technical obstacles
The laser ablation treatment profiles for hyperopia, 
mixed and hyperopic astigmatism are more complex 
than the myopic profiles. The tissue is removed from 
the midperipheral area, thus creating a steeper central 
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area with the increased optical power. for the simple 
hyperopic treatment, the ablation is performed in an-
nular fashion. for the compound hyperopic and mixed 
astigmatism, reduced ablation depths can be achieved 
by hyperopic cylindrical and/or combined cylindrical 
treatment strategies. older laser systems which use 
treatment strategies with the minus cylinder ablation 
profile should be avoided in the treatment of hyperopic 
astigmatism because of the greater ablation depths26.
optical zone and treatment zone sizes are critical 
for the efficacy of the treatment. The designs of the 
optical zone and two transitional zones should avoid 
abrupt steps on the corneal surface, which could lead to 
the regression due to epithelial hyperplasia, especially 
in treatments with smaller optical zones27. The corneal 
eccentricity should be kept within physiological lim-
its. Highly positive eccentricity values of more than 1.2 
following hyperopic laser ablation could lead to corneal 
scars at the point of maximal corneal curvature8. in 
contrast to the hyperopic PRK treatment, the corneal 
flap in LAsiK does not fully follow the shape of hy-
peropic treatment, thus reducing the risk of scarring 
and regression due to epithelial hyperplasia. treating 
corneas with high eccentricity values and inadequate 
transition zones can cause symptoms of glare and halos 
in people with wider pupils. Therefore, hyperopic treat-
ments should be performed with the optical zones of 
more than 5.5 mm and with transition zones of 9 mm, 
which can be achieved with more advanced laser sys-
tems and creation of larger diameter flaps2,28.
Centration and symmetry of the treatments are 
essential in preventing secondary astigmatism and 
higher-order aberrations, coma in particular. steeper 
corneas are more affected by decentration. in order to 
avoid fixation loss during the treatment, the new la-
ser systems utilize eye-tracker systems. There is still 
no consensus whether to use the entrance pupil center 
or the corneal vertex as a reference for the centration 
of laser treatment in hyperopic eyes29. to avoid the 
undercorrection in the eyes with mixed or hyperopic 
astigmatism, cyclotorsional movements should also be 
taken into account. The compensation of cyclotorsion 
can be static and/or dynamic, as with the iris-recogni-
tion based systems.
Excimer Laser Systems – The Present
most of the excimer laser platforms in use today 
have overcome the drawbacks of the early broad beam 
lasers. The beam diameter of broad beam lasers ranged 
from 6 to 8 millimeters. These lasers were controlled by 
the aperture mechanisms and were not suitable for the 
complex hyperopic and astigmatic ablation profiles. 
The more advanced scanning excimer lasers can be 
divided in two categories: the slit scanning and spot 
scanning lasers. The slit scanning lasers use a rotational 
device with the slitholes that enlarge. However, most 
of laser systems used for the correction of hyperopia 
are spot scanning lasers, often referred to as „flying 
spot“ lasers. These lasers use small beams of 0.8 to 2 
millimeters. The beams are scanned across the cornea 
with a high repetitive rate creating a smoother abla-
tion within a smaller amount of time, thus reducing 
the influence of a drying cornea on the final result. The 
spot scanning technology has significantly improved 
the outcomes for the more complex and customized 
ablation profiles for hyperopia and astigmatism. 
due to the limited number of randomized clini-
cal trials and variations in study designs and proto-
cols, such as different range of treatment, nomograms, 
follow-up periods and microkeratomes, it is difficult 
to compare the safety, efficacy, and refractive stabil-
ity of hyperopia, mixed and hyperopic astigmatism 
treatments performed on different laser systems2. A 
brief overview of scanning excimer lasers approved by 
the u.s. food and drug Administration (fdA) from 
2000 to 2011 is given in table 1. 
scanning excimer lasers can safely and effectively 
perform low, moderate, and high hyperopic and hy-
peropic astigmatic corrections with the results com-
parable to the ones obtained when performing myopic 
corrections30,31. However, care must be taken with 
hyperopic treatments greater than +5.00 diopter with 
astigmatism of more than 1.00 diopter because of the 
lower predictability and greater risk of postoperative 
loss of one or more lines of the spectacle-corrected 
visual acuity30,32. in the high hyperopia/astigmatism 
group, there was also a significant increase in higher 
order aberrations. no significant change in higher 
order aberrations was noted in groups with low to 
moderate amounts of hyperopia and hyperopic astig-
matism30. The introduction of new laser systems has 
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also significantly improved the long term refractive 
stability of hyperopic treatments33. 
in recent years, another laser platform, not approved 
by the fdA, is showing promising results. despite the 
increase in the postoperative ocular and corneal higher 
order aberrations, hyperopic LAsiK treatments on the 
Esiris excimer laser (sCHWind eye-tech-solutions) 
have been shown to be safe and effective34.
The Future of Corneal Ablative Laser Surgery
The expansion of scanning laser delivery systems 
during the last decade enabled the domination of cor-
neal ablative laser surgery over other refractive surgical 
procedures for correction of hyperopia, hyperopic and 
mixed astigmatism35. The development of customized 
wavefront-guided treatments has improved the results 
in the eyes with high preexisting higher order aber-
rations. However, a recent meta-analysis of random-
ized controlled trials showed no clear benefit in the 
efficacy, predictability and safety of wavefront-guided 
over the non wavefront-guided ablations36. 
The new generation of mechanical microker-
atomes and femtosecond lasers enabled the creation 
of LAsiK flaps, with a diameter of 9 millimeters or 
more, with excellent safety profiles. The femtosecond 
lasers could have the advantage over the mechanical 
microkeratomes in wavefront-guided LAsiK because 
the planar flaps created by femtosecond lasers do not 
cause significant increase in higher order aberrations37. 
in the future, the femtosecond and nanosecond lasers 
could also be used to reshape the cornea and create 
hyperopic treatment profiles. further contribution to 
the safety and predictability of hyperopic and astig-
Table 1. Food and Drug Administration approved lasers for LASIK treatment of hyperopia, hyperopic and mixed 
astigmatism 2000-2011
device name and type indication Company year of approval 
mEditEC mEL 80 Excimer Laser system
(scanning spot beam)
Hyperopia up to +5.00 d and 
astigmatism from +0.50 d 
to +3.00 d with a maximum 
mRsE of +5.00 d
Carl Zeiss, inc. 2006, 2011
star s4 iR Excimer Laser system with Wavescan 
system 
Visx star Excimer Laser system
(variable scanning spot beam)
Hyperopia up to +3.00 d and 
astigmatism up to +2.00 d





nidek EC-5000 Excimer Laser system
(scanning slit beam)
Hyperopia +0.50 to +5.00 d and 
astigmatism up to +2.00 d nidek, inc. 2000, 2006
Wavelight Allegretto Wave Excimer Laser 
system 
(scanning spot beam with gaussian profile)
Hyperopia up to +6.00 d and 
astigmatism up to +5.00 d with 
a maximum mRsE of +6.00 d
mixed astigmatism up to 6.00 d
 Alcon, inc. / 
Wavelight 2003, 2006
LAdARVision 4000/6000 Excimer Laser system 
LAdARVision Excimer Laser system
(scanning spot beam)
Hyperopia and hyperopic 






tECHnoLAs 217Z Zyoptix system 
tECHnoLAs 217A Excimer Laser system
(scanning spot beam)
Hyperopia up to +4.00 d and 






d = diopter; mRsE = manifest refraction spherical equivalent. source: http://www.fda.gov/medicaldevices/ProductsandmedicalProcedures/
surgeryandLifesupport/LAsiK/ucm192109.htm, accessed february 5, 2012.
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matic treatments could come from faster and more 
comprehensive eye-tracker systems38.
The additional improvements in customized treat-
ments could also prove beneficial, especially in the 
treatment of hyperopic and mixed astigmatism. The 
current customized treatments are based on a single 
diagnostic method, corneal topography or ocular 
wavefront, and depend on approximations39. The opti-
cal ray-tracing method uses data from ocular wave-
front, topography and biometry measurements for 
every optically relevant structure of the eye. These 
data are then used to create an individual eye model 
from which the final custom ablation profile is de-
rived. Recent studies report encouraging results of ray 
tracing-guided LAsiK in the treatment of moderate 
to high myopic astigmatism25. in the future, similar 
algorithms could further increase the upper limits for 
the safe and predictable corneal ablative laser correc-
tion of hyperopia, hyperopic and mixed astigmatism.
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sažetak
isPRAVLJAnJE HiPERoPiJE, HiPERoPiČnog i miJEŠAnog AstigmAtiZmA ExCimER LAsERom: 
JuČER, dAnAs i sutRA
A. Lukenda, Ž. Karaman Martinović i M. Kalauz 
Široka rasprostranjenost nove generacije „spot scanning“ excimer lasera, odnosno lasera s pomičnom točkastom zra-
kom, omogućila je u posljednjih deset godina dominaciju laserske ablacijske kirurgije rožnice u korekciji dalekovidnosti, 
dalekovidnog i miješanog astigmatizma nad drugim refrakcijskim kirurškim postupcima. u članku su navedeni najvažniji 
razlozi zbog kojih je laserska kirurgija rožnice u ispravljanju dalekovidnosti, dalekovidnog i miješanog astigmatizma niz 
godina zaostajala za laserskim ispravljanjem kratkovidnosti. Većina današnjih lasera temeljenih na navedenoj tehnologiji 
omogućuje sigurno i učinkovito ispravljanje niskih, srednjih i visokih dalekovidnosti i astigmatizama uz pomoć postupaka 
LAsiK i PRK. uvođenje ovih laserskih sustava također je unaprijedilo i dugoročnu stabilnost rezultata nakon tretmana. 
može se očekivati da će daljnji napredak u femtosekundnoj i nanosekundnoj tehnologiji, sustavima za praćenje pokreta 
oka, te razvoj novih individualiziranih algoritama poput metode “ray-tracing” u budućnosti pomaknuti današnje granice 
sigurne i predvidljive ablacijske laserske korekcije dalekovidnosti, kao i dalekovidnog i miješanog astigmatizma.
Ključne riječi: Hipermetropni astigmatizam; Dalekovidnost; Astigmatizam; Excimer laser; Laserska in situ keratomileuza 
(LASIK); Fotorefrakcijska keratektomija (PRK); Točkasta zraka; Laser
